Covered recipient · General Payments record
MICHAEL ARMAND AMENT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$536,923.08
- Reported across 943 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $908.31 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $562.06 | 5 |
| Amgen Inc. | $123.06 | 1 |
| PFIZER INC. | $92.81 | 5 |
| ABBVIE INC. | $57.07 | 3 |
| Teva Pharmaceuticals USA, Inc. | $45.00 | 2 |
| Celgene Corporation | $28.31 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.53 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103217775 | CMS |
| ABBVIE INC. | $22.67 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103217777 | CMS |
| ABBVIE INC. | $15.87 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103217779 | CMS |
| Amgen Inc. | $123.06 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115423488 | CMS |
| Celgene Corporation | $13.64 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101173248 | CMS |
| Celgene Corporation | $14.67 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101173258 | CMS |
| Lundbeck LLC | $132.33 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145891645 | CMS |
| Lundbeck LLC | $30.25 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145891647 | CMS |
| Lundbeck LLC | $146.28 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145891649 | CMS |
| Lundbeck LLC | $130.88 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145891651 | CMS |
| Lundbeck LLC | $122.32 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145891653 | CMS |
| PFIZER INC. | $20.78 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131716714 | CMS |
| PFIZER INC. | $18.31 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131757618 | CMS |
| PFIZER INC. | $16.83 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131748070 | CMS |
| PFIZER INC. | $17.30 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131144226 | CMS |
| PFIZER INC. | $19.59 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131216945 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.32 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151511243 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.68 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151511319 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.